Press release
Pulmonary Arterial Hypertension Market: Profound Growth at 9.1% CAGR, Key Trends, and Drivers Forecast
"Remarkable developments in pulmonary arterial hypertension treatments are driving the market forward, projecting strong growth in the coming years.What Is The Projected Market Size Of The Global Pulmonary Arterial Hypertension Market And Its Growth Rate?
From 2024 to 2025, the increase in the pulmonary arterial hypertension market size is expected to trend from $8.47 billion to $9.24 billion. This growth is projected to occur at a compelling compound annual growth rate (CAGR) of 9.1%. Key factors driving growth in this historic period include:
- Increased awareness and diagnosis of pulmonary arterial hypertension (PAH)
- Increased healthcare expenditure
- Growth in aging population
- Expansion of pulmonary arterial hypertension treatment options
- Rise in research and development activities in pulmonary hypertension
The pulmonary arterial hypertension market size is further expected to accelerate to $12.97 billion in 2029, occurring at a CAGR of 8.8%. Growth in this forecast period is set to be attributed to:
- Adoption of novel therapies for pulmonary arterial hypertension
- Increased focus on early detection and diagnosis
- Growing pipeline of PAH drugs and therapies
- Integration of precision medicine in PAH treatment
- Expansion of healthcare infrastructure in emerging markets
What Is Driving The Growth In The Pulmonary Arterial Hypertension Market?
The remarkable upturn in the prevalence of pulmonary arterial hypertension (PAH) disease is a significant driver for the pulmonary arterial hypertension market growth. The rising number of PAH patients necessitating hospitalization and medical care for treatment is expected to catapult the demand for relevant medications in the imminent years. A study published by the National Organization for Rare Disorders, Inc., estimates that each year, the USA sees 500-1000 new cases of PAH, equivalent to one to two individuals per million. Europe presumably depicts similar incidence rates.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5954&type=smp
Who Are the Key Players Driving Pulmonary Arterial Hypertension Market Growth?
Significant players operating in the pulmonary arterial hypertension market comprise:
- United Therapeutics Corporation
- Acceleron Pharma Inc.
- Actelion Pharmaceuticals US Inc.
- Bayer AG
- Eli Lilly and Company
- Gilead Sciences Inc.
- GlaxoSmithKline plc
- Johnson & Johnson
- Liquidia Technologies Inc.
- Lupin Pharmaceuticals Inc.
- Natco Pharma Ltd.
- Pfizer Inc.
- Sandoz AG
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceutical USA Inc.
- Allegheny Health Network
- Cedars-Sinai Medical Center
- Cleveland Clinic
- Houston Methodist Hospital
- Johns Hopkins Medicine
- Massachusetts General Hospital
- Mayo Clinic
- MedStar Heart & Vascular Institute
- National Jewish Health
- NewYork-Presbyterian Hospital
- Ochsner Medical Center
- Royal Brompton & Harefield NHS Foundation Trust
- Rush University Medical Center
- Stanford Health Care
- Swedish Medical Center
- Temple University Hospital
- University of California Health
What Are The Key Trends In The Pulmonary Arterial Hypertension Market?
The imminent forecast period indicates several growing trends in the pulmonary arterial hypertension market. These trends encompass advancements in medical imaging and diagnostic technologies, collaboration and partnerships for drug development, patient-centric approaches in pulmonary arterial hypertension management, and the increased use of combination therapy.
What Are The Segments Of The Global Pulmonary Arterial Hypertension Market?
The pulmonary arterial hypertension market is segmented as follows:
- By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators
- By Route Of Administration: Oral, Intravenous Or subcutaneous, Inhalational
- By Distribution Channel: Retail, Online
Which Region Leads The Pulmonary Arterial Hypertension Market?
North America spearheaded the pulmonary arterial hypertension market in 2024 and covers various spaces including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report
What Is Covered In The Pulmonary Arterial Hypertension Market Global Market Report?
- Market Size Analysis: Analyze the Pulmonary Arterial Hypertension Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pulmonary Arterial Hypertension Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pulmonary Arterial Hypertension Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pulmonary Arterial Hypertension Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=5954&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company:
With more than 15,000 reports spanning 27 industries and over 60 geographies, The Business Research Company is renowned for providing comprehensive data-rich research and valuable insights. Equipped with over 1,500,000 datasets, groundbreaking secondary research, and invaluable perspectives from industry leaders, you gain necessary insights to stay ahead in your industry. Our premier product, the Global Market Model , is a pioneering market intelligence platform providing rigorous forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Market: Profound Growth at 9.1% CAGR, Key Trends, and Drivers Forecast here
News-ID: 3826656 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Open Source Big Data …
The open source big data tool market is set for substantial expansion as the demand for efficient data management solutions grows across industries. With technological advancements and increasing data volumes, the market is evolving rapidly, driven by innovations and rising adoption of scalable and intelligent tools. Let's explore the market's size, leading players, key trends, and segmentation to understand the forces shaping this dynamic sector.
Forecasted Growth and Market Size of…
Emerging Sub-Segments Transforming the Data Provenance Market Landscape
The data provenance market is poised for remarkable expansion in the coming years, driven by rising needs for data transparency and compliance in various industries. As organizations increasingly prioritize trustworthy data management, this sector is set to undergo significant technological advancements and widespread adoption of innovative solutions. Let's delve into the market's size, key players, emerging trends, and segment-specific insights shaping its future trajectory.
Projected Growth Trajectory of the Data Provenance…
Market Trend Insights: The Impact of Emerging Innovations on the New Energy Grid …
The growing emphasis on sustainable energy and smarter grid technologies is transforming how electricity networks operate worldwide. As renewable sources become more prevalent and energy demands evolve, specialized systems for managing grid-connected energy solutions are gaining traction. This overview explores the size, key players, emerging trends, and market segmentation of the new energy grid-connected operation and control system solution sector.
Projected Market Value and Growth Dynamics of the New Energy Grid-connected…
Emerging Growth Patterns Driving Expansion in the Data Lineage for Pipelines Mar …
The data lineage for pipelines market is positioned for remarkable expansion as organizations increasingly seek to enhance transparency and control over their data workflows. With advancing technologies and rising demand for robust data governance, this sector is set to witness significant growth and innovation in the coming years. Below is an overview of market size projections, leading players, trending advancements, and key segmentations shaping the future of this dynamic market.
Projected…
More Releases for Pulmonary
Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,…
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
